MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026

LEUVEN, Belgium, June 17, 2026 (GLOBE NEWSWIRE) --   Regulated information [1]

GlobeNewsWire • Jun 17, 2026

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Jun 15, 2026

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

MTLS, LXFR and ARKO emerged as June breakout stock picks after strong gains and screening tied to price momentum and resistance levels.

Zacks Investment Research • May 29, 2026

Are Investors Undervaluing Materialise (MTLS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • May 12, 2026

Materialise Q1 Earnings Call Highlights

Materialise NASDAQ: MTLS reported first-quarter 2026 revenue of EUR 66.3 million, which Chief Financial Officer Koen Berges said was stable year-over-year despite “significant foreign exchange headwinds,” primarily tied to a weaker U.S. dollar. Gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, helping drive improved profitability and positive free cash flow during the period.

MarketBeat • May 8, 2026

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 7, 2026

Materialise Reports First Quarter 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the first quarter ended March 31, 2026. Additionally, Materialise announced the transfer of its eyewear business to the eyewear management team. Highlights – First Quarter 2026 Total revenue was stable at 66,276 kEUR for the first quarter of 2026 compared.

Business Wire • May 7, 2026

Materialise: The Medical Segment Alone Makes This A Buy

Materialise receives a 'Buy' rating, driven by robust growth in its medical segment despite weakness in software and manufacturing. MTLS's medical segment boasts a 4-year CAGR of 16%, with management guiding for continued strong growth through FY2026. The company maintains a fortress balance sheet with €71m net cash and trades at a significant discount to sector peers on EV/Sales and EV/EBITDA.

Seeking Alpha • Apr 29, 2026

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the first quarter 2026 financial results on Thursday, May 7, 2026 at 8:30 a.m. ET/2:3.

Business Wire • Apr 23, 2026

Materialise to Transfer RapidFit Business to Its Management Team

Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, announces the decision to transfer its RapidFit business to its management team. Following the transaction, RapidFit will continue as an independent company under the ownership and leadership of the same team under the RapidFit name.

GlobeNewsWire • Mar 31, 2026